Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Ondra Health vs PauseRX

Ondra Health
Graded #12

Higher grade

vs+18.299999999999997
PauseRX
Graded #147

Lower grade

The verdict

Ondra Health takes it — 86.8/100 to 68.5/100.

Ondra Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Lowest semaglutide sticker on the board ($93) paired with some brand-name access and LegitScript verification.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueOndra Health +25
91
66
Dose & formulationPauseRX +1
84
85
Clinical oversightOndra Health +3
86
83
Labs & monitoringOndra Health +32
84
52
FulfillmentOndra Health +27
88
61
Contract termsOndra Health +45
86
41
Ondra Health · left barPauseRX · right bar

The numbers

MetricOndra HealthPauseRX
WeighScore86.8/10068.5/100
GradeBC
Scorecard rank#12#147
Semaglutide$93/mo$199/mo
Tirzepatide$166/mo$249/mo (starting dose, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only
Ondra Health

Graded #12 · B

Strengths

  • Lowest listed semaglutide price ($93/mo)
  • Some brand-name access
  • LegitScript-verified, all 50 states

Where it loses points

  • Tirzepatide steps up to $166/mo
  • Labs/monitoring detail not published
  • Compounded-first
PauseRX

Graded #147 · C

Strengths

  • Names its 503A pharmacy partner (Strive Pharmacy, Gilbert AZ) — buyers can independently verify its licensure
  • Names its physician network (Beluga Health) — you can research the clinical platform handling your prescriptions
  • Publishes the FDA compounded-medication disclaimer
  • Corporate legal entity disclosed (PauseRX, Inc.) — uncommon for direct-to-consumer GLP-1 platforms
  • Flat $199 'all doses' compounded semaglutide pricing — no per-tier escalation

Where it loses points

  • States served not listed — site claims nationwide, but you must contact support to confirm availability
  • Restrictive cancellation policy — orders can't be changed or canceled once submitted, and medications can't be returned
  • No named medical director (Beluga Health is the network, not a named MD)
  • LegitScript certification number not shown — badge only, so no direct lookup
  • Insurance not accepted — cash-pay only; HSA/FSA eligibility not confirmed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard